Lioresal Intrathecal (Baclofen) Patent Expiration, LOE Window & CMS Spending

Lioresal Intrathecal (Baclofen) by Amneal Pharmaceuticals: Off-Patent Genericized (AB Competition), 19 AB generics, $5.5M 2024 CMS Part D & Medicaid spend, and $1,890 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAmneal Pharmaceuticals
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors19
2024 CMS Total Public Spend$5.5M
2024 Medicare Part D Spend$405K
2024 Medicaid Spend$5.1M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,890 intro WAC)